Stanley Liauw MD FASTRO

Gastrointestinal Cancer, Urologic Cancer

Professor of Radiation and Cellular Oncology, University of Chicago Medicine

Summary

Dr. Stanley Liauw is a Chicago-based radiation oncologist specializing in gastrointestinal and urologic cancers. He completed his residency in radiation oncology at the University of Florida and an internal medicine internship at Mass General Brigham. He holds a medical degree from the University of Texas Southwestern Medical School and a B.S. in Chemical Engineering with a minor in Biology from MIT. Dr. Liauw is the Director of Clinical Operations at the University of Chicago Medical Center, with expertise in brachytherapy, prostate cancer, stereotactic radiosurgery, and intensity-modulated radiation therapy. His research includes publications on various cancer treatment modalities. He has led clinical trials on kidney and prostate cancer treatments. Dr. Liauw has received multiple CMS Meaningful Use Stage certifications and was awarded the Samuel Hellman Outstanding Teacher of the Year at the University of Chicago.

University of FloridaResidency, Radiation Oncology, 2002 - 2006
Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2001 - 2002
University of Texas Southwestern Medical SchoolClass of 2001
Massachusetts Institute of TechnologyB.S., Major: Chemical Engineering; Minor: Biology, 1993 - 1997

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017

PubMed

A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.
Rohan R Katipally, Greeshma Rajeev-Kumar, Abhishek A Solanki, Fauzia Arif, Scott E Eggener
International Journal of Radiation Oncology, Biology, Physics. 2026-05-01
Pelvic MRI Following Total Neoadjuvant Therapy for Rectal Cancer Poorly Predicts a Complete Clinical Response.
Nicholas R Suss, Ryan Johnson, Kinga S Olortegui, Stanley L Liauw, Ardaman Shergill
Journal of Surgical Oncology. 2026-04-15
FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate pl...
Paul L Nguyen, Marisa A Kollmeier, Dana E Rathkopf, Karen E Hoffman, Amado J Zurita
European Urology. 2026-02-10

Journal Articles

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features
Rahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef M. Michalski, Drew M..., JAMA
Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy
Ying J, Wang CJ, Yan J, Liauw SL, Straka C, Pistenmaa D, Xie XJ, Lotan Y, Roehrborn C, Kim DN, Am J Clin Oncol, 1/9/2015
Randomized Trials and New Directions in Gastrointestinal Cancer
Chang DT, Brunner T, Chia-Hsien Cheng J, Liauw SL, Meyer J, Wo JY, Int J Radiat Oncol Biol Phys, 1/1/2015

Books/Book Chapters

Difficult cases in Radiation Oncology.
Chapter: Difficult cases in Prostate Cancer.
Editors: Small W (ed), Liauw SL (section editor).Demos Medical, New York, NY2012
Therapeutic protein and peptide formulation and delivery, American Chemical Society Symposium Series, vol. 675.
Chapter: The pharmaceutical development of insulin: historical perspectives and future directions.
Page 29 - 66Costantino H, Liauw S, Mitragotri S, Langer R, Klibanov A, Sluzky VEditors: Shahrokh Z, Sluzky V, Cleland JL, Shire SJ, Randolph TW.American Chemical Society, Washington, DC1997

Abstracts/Posters

Endorectal MRI in the Initial Assessment of Prostate Cancer: Radiographic Findings and Impact on Radiotherapeutic Treatment Decisions.
Kropp LM, Oto A, Dess R, Liauw SL, American Society of Therapeutic Radiation Oncology 57th annual meeting, San Antonio, TX, 1/1/2015
Late Toxicity after Post-Prostatectomy Radiation Therapy: Evaluating RTOG 0534 Tissue Sparing Guidelines.
Parekh A, Son CH, Melotek J, Pelizzari C, Hubert G, Liauw SL, American Society of Therapeutic Radiation Oncology 57th annual meeting, San Antonio, TX, 1/1/2015
Urinary, bowel, and sexual quality of life is not worse after whole pelvic post-prostatectomy radiation.
Melotek JM, Liao C, Liauw SL, American Society of Therapeutic Radiation Oncology 56th annual meeting, San Francisco, CA, 1/1/2014

Lectures

Prostate cancer update 2015.
New Orleans, LA - 1/18/2015
Radiation Therapy for Prostate Cancer: An Introduction of Treatment Paradigms for a Developing Program.
Moshi, Tanzania - 1/25/2014
How the outcomes research program at the University of Florida helped shaped the prostate cancer program at the University of Chicago.
Gainesville, FL - 1/21/2014

Other

Post-Operative Prostate and Seminal Vesicle Fossae Contouring Module: Evaluation of Medical Student Target Delineation Before and After a Teaching Intervention.
Gunther J, Liauw S, Choi S, Stepaniak C, Das P, Golden D, MedEdPORTAL Publications
https://www.mededportal.org/publication/10199
1/1/2015
Temperature-induced alteration of skin permeability for drug delivery applications. Undergraduate thesis
Liauw SL, Department of Chemical Engineering and Harvard-MIT Department of Health Sciences Technology
Cambridge, MA - 1/1/1997

More Than 100 UChicago Medicine Physicians Named to Chicago Magazine’s ‘Cancer Fighters’ ListJanuary 22nd, 2026
Cancer Researcher Becomes Cancer PatientFebruary 18th, 2020
Prostate Cancer and Organ Transplantation Not Associated with Prostate Cancer-Specific MortalityDecember 20th, 2019